Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets
AbbVie Deferred Tax Assets and Other Non-Current Assets decreased by 1.7% to $10.54B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.6%, from $9.19B to $10.54B. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets and Other Non-Current Assets shows an upward trend with a 17.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 8, 2026
How to read this metric
An increase generally reflects a growing long-term asset base or deferred tax position, while a decrease suggests asset liquidation or tax benefit utilization.
Detailed definition
This is the aggregate balance of non-current deferred tax assets and other miscellaneous non-current assets not classifi...
Peer comparison
Commonly found in the non-current asset section of balance sheets for large, diversified financial firms.
Metric ID:
deferred_tax_assets_other_noncurrentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.81B | $4.75B | $4.88B | $5.08B | $5.03B | $5.38B | $5.57B | $5.80B | $6.20B | $7.09B | $8.51B | $9.07B | $9.20B | $8.29B | $9.14B | $9.19B | $9.66B | $9.64B | $10.72B | $10.54B |
| QoQ Change | — | -1.3% | +2.9% | +4.1% | -1.0% | +6.9% | +3.5% | +4.1% | +6.9% | +14.5% | +20.0% | +6.5% | +1.4% | -9.9% | +10.3% | +0.5% | +5.1% | -0.2% | +11.2% | -1.7% |
| YoY Change | — | — | — | — | +4.7% | +13.4% | +14.1% | +14.1% | +23.1% | +31.8% | +52.8% | +56.3% | +48.4% | +16.8% | +7.4% | +1.4% | +5.0% | +16.4% | +17.3% | +14.6% |
Range$4.75B – $10.72B
CAGR+18.0%
Avg YoY Growth+21.1%
Median YoY Growth+15.5%
Deferred Tax Assets and Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is AbbVie's deferred tax assets and other non-current assets?
- AbbVie (ABBV) reported deferred tax assets and other non-current assets of $10.54B in Q1 2026.
- How has AbbVie's deferred tax assets and other non-current assets changed year-over-year?
- AbbVie's deferred tax assets and other non-current assets increased by 14.6% year-over-year, from $9.19B to $10.54B.
- What is the long-term trend for AbbVie's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), AbbVie's deferred tax assets and other non-current assets has grown at a 17.2% compound annual growth rate (CAGR), from $4.85B to $10.72B.
- What does deferred tax assets and other non-current assets mean?
- The total value of long-term tax assets and other miscellaneous long-term assets.